Matthew Ackerman

85%
Flag icon
Novo’s convenient pens easily sustained a 30 percent price premium per unit of insulin.
The Innovator's Dilemma: When New Technologies Cause Great Firms to Fail
Rate this book
Clear rating
Open Preview